169349 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
RATIO BETWEEN LTA4H AND METRNL IN THE ASSESSMENT OF POLYCYSTIC OVARIAN SYNDROME
#2Control of Cellular Redox Levels
#3TESTING METHOD AND TESTING REAGENT
#4Therapeutic Substances, their Preparation and Diagnostic Procedure
#5VIMENTIN INHIBITORS
#6METHOD FOR ASSOCIATING WITH EXPRESSION LEVEL OF AKR1C3 ENZYME VIA CONTENT OF PROSTAGLANDIN, AND USE OF SCREENING FOR DRUG ADMINISTRATION
#7Postural Orthostatic Tachycardia Syndrome and CRTH2
#8TREATMENT STRATIFICATION FOR AN EXACERBATION OF INFLAMMATION
#9THERAPEUTIC SUBSTANCES, THEIR PREPARATION AND DIAGNOSTIC PROCEDURE
#10BIOMARKER FOR SENESCENT CELLS
#11CELL POTENCY ASSAY
#12NARCOLEPSY-SPECIFIC MARKERS
#13Modulation of gene expression in a human bioreactor
#14Differential diagnosis of liver disease
#15Antibody against human prostaglandin E2 receptor EP4
#16Kit and method for measuring prostaglandin E-major urinary metabolite
#17FOOD ALLERGY BIOMARKER, FOOD ALLERGY TESTING METHOD, KIT FOR URINE SAMPLE TESTING, AND STICK FOR URINE SAMPLE TESTING
#18ANTIBODY WHICH SPECIFICALLY BINDS TO HUMAN CRTH2
#19CELL POTENCY ASSAY
#20Peripheral measure of central brain inflammation, markers therefor and uses thereof
#21METHOD FOR EXAMINING FOOD ALLERGY AND EXAMINATION KIT
#22Method of differentiating stable angina pectoris from acute coronary syndrome and diagnostic kit thereof
#23Control of Cellular Redox Levels
#24Control of Cellular Redox Levels
#25Control of Cellular Redox Levels
#26Methods and compositions for identifying non-alcoholic fatty liver disease
#27SYSTEM FOR ASSESSING DRUG EFFICACY AND RESPONSE OF A PATIENT TO THERAPY
#28Control of cellular redox levels
#29Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
#30Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
#31Differential diagnosis of liver disease
#32STRESS AND INFLAMMATION BIOMARKER URINE PANEL FOR DAIRY COWS AND BEEF CATTLE
#33Antibody against human prostaglandin E2 receptor EP4
#34Early Predictive Markers of Pre-Eclampsia
#35PROSTAGLANDIN E2 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#36Methods to determine susceptibility to treatment with leukotriene modifiers
#37Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
#38Diagnostic tools for charcot-marie-tooth disease
#39Antibody against human prostaglandin Ereceptor EP4
#40INHIBITORS AND METHODS OF TREATMENT OF CARDIOVASCULAR DISEASES, AND METHODS FOR IDENTIFYING INHIBITORS
#41Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
#42Patient Selection and Therapeutic Methods Using Markers of Prostaglandin Metabolism
#43Reagent and method for detection of carboxylic acids by mass spectrometry
#44Methods and kits for detection of thromboxane A2 metabolites
#45Methods for assessing drug efficacy and response of patient to therapy
#46METHODS FOR THE REGULATION OF THE PROSTAGLANDIN F SYNTHASE (PGFS) ACTIVITY OF AKR1B1 AND USES THEREOF
#47DIAGNOSIS AND TREATMENT OF BACK PAIN
#48Method for determining the stage of ulcerative colitis or interstitial pneumonitis and reagent kit thereof
#49METHODS RELATING TO BREATHING DISORDERS
#50Prostaglandin E2 modulation and uses thereof
#51Inflammation and Oxidative Stress Level Assay
#52TREATMENT AND PREVENTION OF ISCHEMIC BRAIN INJURY
#53Methods and kits for detection of thromboxane A2 metabolites
#54Method for Analyzing Clinical Trial Results for Efficacy of a Therapy
#55BIOMARKERS OF INFLAMMATION
#56Detection of hypertension using glucuronidated metabolic products
#57Assays For Detecting Inhibitors Of Binding Between COX-2 And PDZ Proteins
#58Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease
#59Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
#60METHOD FOR PREDICTING CARDIOVASCULAR EVENTS
#61TEST KIT FOR DETECTING PERIODONTAL DISEASE
#62Methods for identifying modulators of eoxin formation
#63Methods to determine susceptibility to treatment with leukotriene modifiers
#64Method of measuring the activity of G(alpha)i- or G(alpha)o-coupled receptors using Ca influx in cells
#65Method for determining the stage of ulcerative colitis or interstitial pneumonitis and reagent kit thereof
#66METHOD FOR SCREENING OF PROSTAGLANDIN COMPOUNDS COMPRISING AN OPTIMAL FORMULATION FOR THE ENHANCEMENT OF HAIR GROWTH AND THE STIMULATION OF FOLLICULAR ANAGEN AND FORMULATIONS RESULTING THEREFROM
#67PROSTAGLANDIN E2 MODULATION AND USES THEREOF
#68Small molecule inhibitors of PDZ interactions
#69Methods for monitoring patients with severe sepsis and septic shock and for selecting treatments for these patients
#70Methods for identifying inhibitors of vascular injury
#71Method of identifying an inhibitor of the prostanoid EP4 receptor
#72Methods for identifying and monitoring patients at risk for systemic inflammatory conditions, methods for selecting treatments for these patients and apparatus for use in these methods
#73Detection of Preterm Labour
#74Methods for Determining the Potency, Specificity, and Toxicity of Hematopoietic Prostaglandin D2 Synthase
#75Methods and compositions for the treatment of neurological diseases and disorders
#76Methods and kits for detection of thromboxane A2 metabolites
#77Methods of identifying anti-inflammatory macrolides
#78Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep1 (prostaglandin e2 ep1)
#79Assays for detecting inhibitors of binding between COX-2 and PDZ proteins
#80Prostaglandin receptor EP1
#81PGE-M as a biomarker of pulmonary inflammation
#82Method and system for stabilization of arachidonic acid for use in platelet function assay
#83Detection of hypertension using glucuronidated metabolic products
#84Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylgycerol metabolites
#85Human prostaglandin FP receptor variants and methods of using same
#86Methods for determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthase
#87Method of measuring the activity of G(alpha)i- or G(alpha)o-coupled receptors using Ca2+ influx in cells
#88Drugs for improving the prognosis of brain injury and a method of screening the same
#89Drugs for improving the prognosis of brain injury and a method of screening the same
#90Diagnostic method based on lipid measuring parameter modulations/effector quotient profiles
#91Treatment of BPH